Multiple correlations analysis of different cholesterol-reducing drugs

Abstract

In this research, multiple correlation analyses of different cholesterol-reducing drugs were examined. There have been several arguments by physicians as to which anti-cholesterol drugs are the best to administer. To solve this problem, four cholesterol-reducing drugs-statin, proprotein convertase subtilisin/kexin (PCSK) inhibitors, fibrates, and nicotinic acid were experimented. The result shows that the drugs are statistically significant and that combining statin and PCSK qlutubitor is the best combination to be administered to the patient.